The following is from an article published in MDPI – Publisher of Peer Reviewed Open Access Journals.

A new study illustrates that the onset of debilitating symptoms following SARS-CoV-2 vaccination is thought to constitute a new, novel disease entity, for which the term post-acute Covid-19 vaccination syndrome (PACVS) has been suggested.

The symptoms reported by PACVS-affected persons start shortly after SARS-CoV-2 vaccination, continue in episodes over several months, and severely compromise the quality of life.

A systematic survey of the clinical features of PACVS has yet to be carried out.